At present, there are over 10,000 single gene genetic diseases in humans, affecting approximately one percent of the global population. The amount of human genome data is very large, but exon regions constitute only 2% of it, and 85% of genetic diseases occur in exon regions. Therefore, under economic constraints, focusing on detecting exons is an effective approach to identifying the causes of genetic diseases.
Economical---The exome accounts for only 1% ~ 2% of the human genome, and exons can encode amino acids for translation into functional proteins, covering most of the functional variations associated with individual phenotypes.
Authoritative---The disease-database is updated regularly to keep up with the progress of clinical frontiers and improve the detection rate.
Comprehensive---In-depth analysis and interpretation guide, with a comprehensive case management system, powerful NGS annotation, interpretation, exclusive database system, and customized reports.
Suspected patients with monogenic genetic diseases
Patients with clinical critical illness and difficult prognosis judgment who need a clear diagnosis and choose a precise treatment plan
Patients with complex diseases and syndromes with complex etiologies and difficult to be diagnosed by routine diagnosis
High risk population with family history of genetic disease
Couples who have a family history of genetic disease or have given birth to a child who needs prenatal diagnosis or genetic counseling
Precise diagnosis: find the genetic causes of genetic diseases and identify the disease types with similar phenotypes
Guiding treatment&prognosis: finding and designing personalized treatment plans based on the causes of the disease. Early prevention and intervention should be carried out for individuals carrying pathogenic variants identified through cascade screening, in order to stay away from the triggering factors of the disease.
Guiding fertility: designing a fertility plan to reduce the birth rate of children
Assisted scientific research: promoting the study of the pathogenesis and treatment exploration of related diseases
Nucleic acid extraction
Library construction
Probe hybridization
Magnetic bead capture
Target sequence capture
High-throughput sequencing
Result interpretation & Report
15 working days after receiving qualified samples.